comparemela.com

Latest Breaking News On - அசிஸ்ல் ஆராய்ச்சி - Page 1 : comparemela.com

DeLand teens getting Novavax vaccines as part of trial

DeLand teens getting Novavax vaccines as part of trial Alexa Lorenzo, Adam Poulisse About 4.1 million young people ages 12 to 17 have got their first COVID-19 shot. The only shot they can get is the Pfizer vaccine. But tucked away in DeLand, dozens of children are getting the Novavax COVID-19 vaccine. It’s part of the company’s vaccine trial for 12- to 17-year-olds playing out at Accel Research in DeLand. “I just wanted it,” said 14-year-old volunteer Madison White. The Clermont teen has wanted the shot for a while, but her mom Allisa White said, “She asked me if she would be able to get the vaccine a few weeks ago and, at that time, it wasn’t available for kids her age.”

DeLand COVID vaccine research site seeking children for Novavax trials

DeLand COVID vaccine research site seeking children for Novavax trials Alexa Lorenzo, Charles Frazier © Provided by WFTV Orlando A new COVID-19 vaccine research site in DeLand is seeking kids aged 12 to 17 to participate in a trial. The doctors conducting the trials say they’ll play a major role in the effort to reach herd immunity against the virus in Central Florida. Though kids are less likely than older adults to become seriously ill from a COVID-19 infection, studies show they still contribute significantly to transmission of the virus. That’s why pharmaceutical companies are working to make sure their vaccines work for children too.

Novavax seeks children 12-17 for paid COVID-19 vaccine clinical trial

Novavax seeks children 12-17 for paid COVID-19 vaccine clinical trial Published  Novavax seeks children 12-17 for paid COVID-19 vaccine clinical trial Novavax Inc. is awaiting approval from the U.S. Food and Drug Administration for emergency use authorization of its COVID-19 vaccine. In Central Florida, the company is starting paid clinical trials in DeLand and Lakeland to see how effective the same vaccine is on teenagers. LAKE MARY, Fla. - Novavax Inc. is awaiting approval from the U.S. Food and Drug Administration (FDA) for emergency use authorization of its COVID-19 vaccine. The company received $1.6 billion last year from the federal government to speed up testing and production. As it nears completion of its Phase 3 trials for its COVID-19 vaccine, which was found to be nearly 90% effective during clinical testing in the United Kingdom, it is grabbing headlines around the world.

Researchers need teen volunteers for COVID-19 children vaccine trial in Florida

Researchers need teen volunteers for COVID-19 children vaccine trial in Florida 50 volunteers between the ages of 12-17 sought for study Accel Research Sites is conducting a clinical trial in Lakeland for the Novavax pediatric coronavirus vaccine. By: Rebecca Petit and last updated 2021-04-27 13:51:28-04 LAKELAND, Fla. — Accel Research Sites wants to get the word out that they are conducting a clinical trial in Florida for the Novavax pediatric coronavirus vaccine. The trial, which is being held in Lakeland, is seeking at least 50 volunteers between the ages of 12-17, and participants will be compensated. We’ll need the parents with the adolescent to sign consent and assist them with all the requirements of the study, including make sure all the diaries are done, said Dr. Bruce Rankin, Medical Director of Accel Clinical Research.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.